Chen, V.C.-H.; Huang, S.-L.; Huang, J.-Y.; Hsu, T.-C.; Tzang, B.-S.; McIntyre, R.S.
Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis. Int. J. Mol. Sci. 2023, 24, 12630.
https://doi.org/10.3390/ijms241612630
AMA Style
Chen VC-H, Huang S-L, Huang J-Y, Hsu T-C, Tzang B-S, McIntyre RS.
Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis. International Journal of Molecular Sciences. 2023; 24(16):12630.
https://doi.org/10.3390/ijms241612630
Chicago/Turabian Style
Chen, Vincent Chin-Hung, Shao-Lan Huang, Jing-Yu Huang, Tsai-Ching Hsu, Bor-Show Tzang, and Roger S. McIntyre.
2023. "Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis" International Journal of Molecular Sciences 24, no. 16: 12630.
https://doi.org/10.3390/ijms241612630
APA Style
Chen, V. C. -H., Huang, S. -L., Huang, J. -Y., Hsu, T. -C., Tzang, B. -S., & McIntyre, R. S.
(2023). Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis. International Journal of Molecular Sciences, 24(16), 12630.
https://doi.org/10.3390/ijms241612630